Síndrome de Cushing iatrogénico por corticoides inhalados en paciente VIH

Alondra Frías ^[1] ; Alex Ortiz ^[1] ; Miriam Soto ^[1] ; Francisco Muñoz ^[2] ; Carolina Chacón ^[2]
1. [1] Universidad Católica del Maule
  
  Universidad Católica del Maule
  
  Provincia de Talca, Chile
2. [2] Hospital Regional de Talca
  
  Hospital Regional de Talca
  
  Provincia de Talca, Chile
Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 144, Nº. 7, 2016, págs. 931-936
Idioma: español
Títulos paralelos:
- Cushing syndrome in a HIV patient using inhaled steroids. Report of one case
Enlaces
- Texto completo
Resumen
- We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months.